ReadyRx NAD+ Rx Claims Evaluated: 2026 Update Highlights Changes in Prescription NAD+ Nasal Spray and Injection Access, Pricing, and Telehealth Eligibility
Cheyenne, WY, April 10, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is…
Emergent BioSolutions Launches New NARCAN Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness
GAITHERSBURG, Md., April 07, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:…
New SPRAVATO (esketamine nasal spray) data support robust effectiveness and show durable effect for treatment resistant depression in a real-world setting
Johnson & Johnson presents findings from the largest European real-world dataset for…
Milestone Receives FDA Approval of CARDAMYST (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (PSVT)
First FDA approved treatment in 30+ years for more than 2 million…
First market launch of the adrenaline nasal spray, EURneffy, for treatment of adults and children in Germany
ALK (ALKB:DC / OMX: ALK B) today announced the first market launch…
Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study
EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal…
